HSPA5 and nasopharyngeal carcinoma: Additionally, research has reported that salidroside may inhibit nasopharyngeal carcinoma proliferation by up-regulating miR-4262, which targets Glucose-regulated protein 78 (GRP78) (48) The current study has systematically elucidated for the first time the mechanism by which salidroside inhibits gastric cancer through lipid metabolism pathways, providing a theoretical basis for salidroside to inhibit gastric cancer through miRNA.